Academic warns next-gen medtech held back by cost and regulation

Med-Tech Innovation March 14, 2024

Next generation medical technologies with the potential to transform NHS treatments for conditions such as osteoarthritis are being held back by over-complicated regulations and high costs, a leading academic has warned.

Almost nine million people in the UK are affected by osteoarthritis where the cartilage between bones – most commonly the knees and hips – is worn away, causing the joint to become painful and swollen.

The Bioprinting Technology Platform in the Henry Royce Institute at The University of Manchester is examining ways to improve patient outcomes by 3D printing new cartilage made from the patient’s cells in combination with advanced biomaterials. This strategy, known as bioprinting, seeks to stimulate the body’s own regenerative capacity to restore rather than repair...

Today's Sponsors

Today's Sponsor